Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer

Tobacco is a known risk factor for lung cancer, and continued tobacco use is associated with poorer outcomes across multiple lung cancer treatment modalities including surgery, chemotherapy and radiation therapy. Less is known about the association of tobacco use and outcomes with immune checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales: Corke, Lucy K., Li, Janice J. N., Leighl, Natasha B., Eng, Lawson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498279/
https://www.ncbi.nlm.nih.gov/pubmed/36135061
http://dx.doi.org/10.3390/curroncol29090492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498279/
https://www.ncbi.nlm.nih.gov/pubmed/36135061
http://dx.doi.org/10.3390/curroncol29090492

Ejemplares similares